Patients With COPD May Soon Benefit From the Chiesi Farmaceutici's Investigation Into a Fixed Triple Combination ICS/LABA/LAMA
June 07, 2016 08:00 ET
|
Chiesi USA, Inc.
PARMA, ITALY--(Marketwired - June 07, 2016) - Chiesi is the first Company to complete 2 multicenter long-term clinical studies with a fixed triple combination for COPDThe preliminary results of the...
An Extrafine ICS/LABA Combination Decreases COPD Exacerbations More Than LABA/LAMA: a Comparative Analysis Versus Bronchodilator Monotherapy
May 18, 2016 08:00 ET
|
Chiesi USA, Inc.
PARMA, ITALY--(Marketwired - May 18, 2016) - In the treatment of chronic obstructive pulmonary disease (COPD) the combination of inhaled corticosteroids (ICS) and long acting bronchodilators...
Chiesi to Acquire 3 Hospital Products - Kengreal(R), Cleviprex(R), Argatroban for Injection
May 09, 2016 07:00 ET
|
Chiesi USA, Inc.
PARMA, ITALY--(Marketwired - May 09, 2016) -
Chiesi USA, Inc. and Chiesi Farmaceutici S.p.A., Chiesi USA's parent company, announced today that the companies have agreed to acquire...
80 Years of Innovation and Success in Healthcare: Chiesi Reports Significant International Growth in 2015
March 30, 2016 09:15 ET
|
Chiesi USA, Inc.
PARMA, ITALY--(Marketwired - March 30, 2016) -
Chiesi Farmaceutici generated just under EUR1.5bn in revenue in 2015, a year-on-year increase of almost 10%.
The...
Chiesi USA, Inc. Certified as One of the Top Employers USA 2016
February 10, 2016 07:00 ET
|
Chiesi USA, Inc.
CARY, NC--(Marketwired - February 10, 2016) - Chiesi USA, Inc. announced today that the Top Employers Institute has named the company a Top Employer in the United States for 2016. The Top...
Chiesi USA Presents: Pioneering Innovative Research and Philanthropy in the Neonatal Community
February 20, 2015 11:06 ET
|
Chiesi USA, Inc.
ORLANDO, FL--(Marketwired - February 20, 2015) - Chiesi USA, dedicated to assisting with the advancement of neonatal research, hosted a complimentary seminar to provide a glimpse of the latest...
Chiesi USA Partners With March of Dimes for Prematurity Awareness Month
November 13, 2014 09:02 ET
|
Chiesi USA
CARY, NC--(Marketwired - Nov 13, 2014) - Chiesi USA, dedicated to assisting with the advancement of neonatal research and the treatment of preterm infant Respiratory Distress Syndrome (RDS), has...
Cornerstone Therapeutics Inc. Announces Name Change to Chiesi USA, Inc.
April 28, 2014 11:41 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwired - Apr 28, 2014) - Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on commercializing products for the U.S. hospital and adjacent specialty...
Digestive Care, Inc. Donates Year-Long Supply of PERTZYE(R) (Pancrelipase) to Cystic Fibrosis Patients in El Salvador
March 10, 2014 09:05 ET
|
Cornerstone Therapeutics
BETHLEHEM, PA--(Marketwired - Mar 10, 2014) - Digestive Care, Inc. (DCI), the manufacturer of PERTZYE® (pancrelipase) and its marketing partner in the U.S. cystic fibrosis (CF) market,...
Cornerstone Therapeutics Inc. Stockholders Approve Merger
February 03, 2014 14:24 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwired - Feb 3, 2014) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) (the "Company" or "Cornerstone"), a specialty pharmaceutical company focused on commercializing products for the...